Tandem Diabetes Care Long Term Debt

As of the most recent data (June 2026), TNDM shows a long-term debt of $720M. That compares with $430M in the prior-year period — up 67.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TNDM's long-term debt is now $720M (was $430M) — a 67.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tandem Diabetes Care is outperforming or lagging.

Tracking TNDM's long-term debt over time shows whether Tandem Diabetes Care is scaling, shrinking, or reshaping that part of the business. The current reading is $720M That compares with $430M in the prior-year period — up 67.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Tandem Diabetes Care's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $720M) with ownership activity and broader fundamentals.

Tandem Diabetes Care's long-term debt is $720M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.